87 FR 152 pgs. 48511-48512 - Importer of Controlled Substances Application: Curium US LLC
Type: NOTICEVolume: 87Number: 152Pages: 48511 - 48512
Pages: 48511, 48512Docket number: [Docket No. DEA-1059]
FR document: [FR Doc. 2022-17008 Filed 8-8-22; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1059]
Importer of Controlled Substances Application: Curium US LLC
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
Curium US LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before September 8, 2022. Such persons may also file a written request for a hearing on the application on or before September 8, 2022.
ADDRESSES:
[top] The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.34(a), this is notice that on July 8, 2022, Curium US LLC, 2703 Wagner Place, Maryland Heights, Missouri 63043-3421, applied to be registered as an importer of the following basic class(es) of controlled substance(s):
Controlled substance | Drug code | Schedule |
---|---|---|
Ecgonine | 9180 | II |
The company plans to import small quantities of a derivative form of the listed controlled substance to be used in diagnostic testing. No other activities for this drug code is authorized for this registration.
Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale.
Kristi O'Malley,
Assistant Administrator.
[FR Doc. 2022-17008 Filed 8-8-22; 8:45 am]
BILLING CODE P